Tenet Reports Results for the Third Quarter Ended September 30, 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Paradium AI (PAAI) Halted, News Pending
Tenet Healthcare (THC) PT Raised to $33 at Mizuho Securities
November 5, 2019 11:59 AM ESTMizuho Securities analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $33.00 (from $30.00) while maintaining a Buy rating.
The analyst commented, "We are raising our price target on THC to $33 (from $30) post a solid 3Q:19. Volume growth accelerated... More
Tenet Healthcare (THC) Tops Q3 EPS by 28c, Offers Q4 Guidance
November 4, 2019 4:21 PM ESTTenet Healthcare (NYSE: THC) reported Q3 EPS of $0.58, $0.28 better than the analyst estimate of $0.30. Revenue for the quarter came in at $4.57 billion versus the consensus estimate of $4.46 billion.
GUIDANCE:
Tenet Healthcare sees Q4 2019 EPS of $0.57-$1.23, versus the consensus of $1.00.... More
